Connie L. Davis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Connie L. Davis has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Alan H. Wilkinson
Department of Medicine, Divisions of Nephrology and Transplantation, University of California at Los Angeles, Los Angeles, CA
2 shared publications- Christopher Lee Marsh
Scripps Center for Organ Transplantation, Scripps Clinic and Green Hospital, La Jolla, CA
2 shared publications Thomas A. Gonwa
Department of Medicine, Divisions of Nephrology and Transplantation, Mayo Clinic Transplant Center, Jacksonville, FL
2 shared publicationsA. Wilkinson
Department of Medicine, University of California at Los Angeles, Los Angeles, CA
1 shared publicationAnnamaria T. Kausz
Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington
1 shared publicationCharles E. Alpers
1 shared publication
Latest Publications
- 1 October 2010
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (10) , 1873-1880
The State of U.S. Living Kidney Donors
Background and objectives: Increasing living kidney donation mandates ongoing assessment of living donors for future health risks and revision of national health policy. Design, setting, participants, & measurements: Living kidney donors as reported to the Organ Procurement and Transplant Network database from January 1988 through December 2008 were reviewed for minor medical abnormalities, presence of donor health care coverage, and occurrence of surgical complications and death. Results: At donation in 2008, 19.5% were obese, 2.0% had a history of hypertension, and 3.5% had proteinuria. The median estimated GFR of living donors was 92.2 ml/min. Additionally, 12.2% of donors were reported not to have health insurance at the time of donation. By racial background, 14.9% of black and 17.0% of Hispanic donors did not have insurance at donation. Perioperative complications included blood transfusion (0.4%), reoperation (0.5%), and vascular complications (0.2%). Death occurred within 30 days of donation in 0.03% donating between October 1999 and December 2008. During those same years, overall donor death was 2.8%. Conclusions: Almost one quarter of living donors have medical conditions that may be associated with future health risk. Close follow-up and a registry of these donors are necessary. Only then will we be able to inform prospective living donors most accurately of the real risk of donation on their health and survival. Additionally, these data speak to the need for a national discussion on the provision of health insurance for living donors.
- 1 October 2010
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (10) , 1873-1880
The State of U.S. Living Kidney Donors
Background and objectives: Increasing living kidney donation mandates ongoing assessment of living donors for future health risks and revision of national health policy. Design, setting, participants, & measurements: Living kidney donors as reported to the Organ Procurement and Transplant Network database from January 1988 through December 2008 were reviewed for minor medical abnormalities, presence of donor health care coverage, and occurrence of surgical complications and death. Results: At donation in 2008, 19.5% were obese, 2.0% had a history of hypertension, and 3.5% had proteinuria. The median estimated GFR of living donors was 92.2 ml/min. Additionally, 12.2% of donors were reported not to have health insurance at the time of donation. By racial background, 14.9% of black and 17.0% of Hispanic donors did not have insurance at donation. Perioperative complications included blood transfusion (0.4%), reoperation (0.5%), and vascular complications (0.2%). Death occurred within 30 days of donation in 0.03% donating between October 1999 and December 2008. During those same years, overall donor death was 2.8%. Conclusions: Almost one quarter of living donors have medical conditions that may be associated with future health risk. Close follow-up and a registry of these donors are necessary. Only then will we be able to inform prospective living donors most accurately of the real risk of donation on their health and survival. Additionally, these data speak to the need for a national discussion on the provision of health insurance for living donors.
- 1 July 2009
- Published by Elsevier in Advances in Chronic Kidney Disease
- Vol. 16 (4) , 242-249
Living Kidney Donors: Current State of Affairs
- 1 July 2009
- Published by Elsevier in Advances in Chronic Kidney Disease
- Vol. 16 (4) , 242-249
Living Kidney Donors: Current State of Affairs
- 28 May 2009
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (22) , 2370-2372
Long-Term Consequences of Kidney Donation
The outcomes for living kidney donors, shown in the study by Ibrahim et al. (Jan. 29 issue),1 are reassuring. Key strengths of the study are the large sample and the long follow-up. However, limitations include a highly selected and ethnically homogeneous population and the lack of acknowledgment that living donors today have an increasing number of health risk factors such as obesity. Also missing are considerations of the effect of unique regional practices and rates of end-stage renal disease (ESRD), socioeconomic influences, access to health care, educational level, and lifestyle choices. We would argue that the good survival and lower overall rate of ESRD as compared with the rates in the general population may have been due to the optimal condition of the donors at the time of their donation. The rate of ESRD should have been reported according to geographic area, since the rate varies substantially across the country. Furthermore, the ideal control group is not the general population but a group of people living in the same area who have been evaluated as candidates for donation but who did not donate. Even with the excellent research design, this study cannot be taken as the final word. Potential donors of nonwhite background need to be very carefully screened and counseled.2,3
- 28 May 2009
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (22) , 2370-2372
Long-Term Consequences of Kidney Donation
The outcomes for living kidney donors, shown in the study by Ibrahim et al. (Jan. 29 issue),1 are reassuring. Key strengths of the study are the large sample and the long follow-up. However, limitations include a highly selected and ethnically homogeneous population and the lack of acknowledgment that living donors today have an increasing number of health risk factors such as obesity. Also missing are considerations of the effect of unique regional practices and rates of end-stage renal disease (ESRD), socioeconomic influences, access to health care, educational level, and lifestyle choices. We would argue that the good survival and lower overall rate of ESRD as compared with the rates in the general population may have been due to the optimal condition of the donors at the time of their donation. The rate of ESRD should have been reported according to geographic area, since the rate varies substantially across the country. Furthermore, the ideal control group is not the general population but a group of people living in the same area who have been evaluated as candidates for donation but who did not donate. Even with the excellent research design, this study cannot be taken as the final word. Potential donors of nonwhite background need to be very carefully screened and counseled.2,3
- Open Access
- 27 April 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (5) , 455-456
What's in a name, AKI?
- 27 April 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (5) , 455-456
Open AccessWhat's in a name, AKI?
- 1 July 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9632) , 10-11
Sex mismatches in kidney transplantation
- 1 July 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9632) , 10-11
Sex mismatches in kidney transplantation
- 3 January 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (1) , 98-99
Book Review Medical Complications of Kidney Transplantation By Claudio Ponticelli. 425 pp., illustrated. Abingdon, England, Informa Healthcare, 2007. $229.95. 978-0-415-41715-0
Medical Complications of Kidney Transplan tation is a wonderful reference that details the problems that can develop in recipients of kidney transplants: allograft dysfunction, cancer, infection, hematologic diseases, skin lesions, cardiovascular events, and musculoskeletal, ocular, and neurologic disturbances. It is a complete compilation of author Claudio Ponticelli's extensive experience and insight into the art of transplantation medicine, combined with a review of the medical literature on the subject. The book is easy to read, is nicely illustrated, and includes useful tables.
- 3 January 2008
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (1) , 98-99
Book Review Medical Complications of Kidney Transplantation By Claudio Ponticelli. 425 pp., illustrated. Abingdon, England, Informa Healthcare, 2007. $229.95. 978-0-415-41715-0
Medical Complications of Kidney Transplan tation is a wonderful reference that details the problems that can develop in recipients of kidney transplants: allograft dysfunction, cancer, infection, hematologic diseases, skin lesions, cardiovascular events, and musculoskeletal, ocular, and neurologic disturbances. It is a complete compilation of author Claudio Ponticelli's extensive experience and insight into the art of transplantation medicine, combined with a review of the medical literature on the subject. The book is easy to read, is nicely illustrated, and includes useful tables.
- 1 January 2008
- Published by Elsevier in Transplantation Reviews
- Vol. 22 (1) , 82-88
Controversies in combined liver-kidney transplantation: indications and outcomes
- 1 January 2008
- Published by Elsevier in Transplantation Reviews
- Vol. 22 (1) , 82-88
Controversies in combined liver-kidney transplantation: indications and outcomes
- Open Access
- 31 August 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (10) , 2219-2220
Variable Evaluation and Selection Criteria for Living Kidney Donors: Have We Gotten the Message Yet?
- 31 August 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (10) , 2219-2220
Open AccessVariable Evaluation and Selection Criteria for Living Kidney Donors: Have We Gotten the Message Yet?
- Top Cited PapersOpen Access
- 26 May 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (7) , 1702-1709
Simultaneous Liver–Kidney Transplantation: Evaluation to Decision Making
- 26 May 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (7) , 1702-1709
Top Cited PapersOpen AccessSimultaneous Liver–Kidney Transplantation: Evaluation to Decision Making
- 1 July 2006
- Published by Springer Nature in Nature Clinical Practice Nephrology
- Vol. 2 (7) , 362-363
Nephrectomy for end-stage polycystic kidney disease can be performed safely at the time of transplantation
- 1 July 2006
- Published by Springer Nature in Nature Clinical Practice Nephrology
- Vol. 2 (7) , 362-363
Nephrectomy for end-stage polycystic kidney disease can be performed safely at the time of transplantation